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Background: Disorders of endocrine substances in epicardial adipose tissue are known causes of coronary artery
disease (CAD). Adiponectin is associated with cardiovascular disease. However, expression of adiponectin in
epicardial adipose tissue and its function in CAD pathogenesis is unclear. This study investigates adiponectin
expression in epicardial adipose tissue in CAD patients.
Methods: Vessels or adipose tissue samples collected from CAD patients and non-CAD controls were examined
after immunochemical staining. Adiponectin, cytokines of interleukin-6 (IL-6) and necrosis factor-a (TNF-a) and toll-
like receptor 4 (TLR4) expression level in adipose tissue were measured using real-time quantitative RT-PCR.
Adiponectin concentrations in peripheral and coronary sinus vein plasma were measured with enzyme-linked
immunosorbent assay. Peripheral vein plasma biochemistries were performed with routine laboratory techniques.
Monocytes were collected from blood using lymphocyte separation medium. Expression level of cytokines and
transcription factor NF-B were measured to learn the effect of adiponectin on stearic acid-stimulated monocytes.
Percentage of TLR4 positive monocytes was analyzed using flow cytometry.
Results: Histological examination revealed increased macrophage infiltration into epicardial adipose tissue of CAD
patients. Decreased adiponectin displayed by real-time quantitative RT-PCR was associated with enhanced
cytokines of IL-6 and TNF-a or TLR4 expression level in epicardial adipose tissue, suggesting decreased circulating
adiponectin may be useful as a more sensitive predictor for coronary atherosclerosis than routine laboratory
examinations. Adiponectin suppressed secretion of IL-6 and TNF-a in stimulated monocytes and TLR4 was
expressed on cell surfaces.
Conclusions: Endocrine disorders in epicardial adipose tissue are strongly linked to CAD, and adiponectin has a
protective effect by inhibiting macrophage-mediated inflammation.
Background
Obesity plays a causative role in the pathogenesis of cor-
onary artery disease (CAD), including primary athero-
sclerotic and restenotic changes after coronary artery
bypass grafts (CABG). Adipose tissue is an organ that
stores fat, as well as an active endocrine organ that
secretes various types of bioactive molecules, including
leptin [1], adiponectin [2], resistin [3], plasminogen acti-
vator inhibitor-1 [4,5], apelin [6], Tumor necrosis fac-
tor-a (TNF-a) [7] and interleukin-6 (IL-6) [8]. Fat
distribution also influences the occurrence and develop-
ment of cardiovascular disease [9-11]. Compared to peo-
ple with fat localized to the buttocks and hips, those
with central obesity (i.e., with a larger waist circumfer-
ence) are at higher risk, suggesting that visceral fat has
different biological characteristics and plays a more
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any medium, provided the original work is properly cited.Epicardial adipose tissue has properties of visceral fat
[9]. Recent research has shown that disorders of endo-
crine substances secreted by this tissue can induce
inflammation that contributes to the occurrence of car-
diovascular disease [12]. However, its function in the
progression of atherosclerosis and the potential endo-
crine function of myocardial metabolism are still under
observation, and the molecular mechanism by which
adipocyte factor acts on myocardial tissue and the cor-
onary artery has not be confirmed.
Adiponectin is one of several important active cyto-
kines secreted from adipose tissue. Epidemiologic studies
have associated low-circulating levels of this adipokine
with various cardiovascular diseases including CAD [13].
However, to our knowledge, adiponectin secretion in epi-
cardial adipose tissue has not been reported. High con-
centrations of free fatty acid (FFA) can stimulate the
conversion of monocytetomacrophage and promote
transformation of macrophages into foam cells in an
inflammatory microenvironment, which contributes to
the formation of coronary atherosclerosis [5]. From this
point of view, we have investigated adiponectin expres-
sion in epicardial adipose tissue and the effect of adipo-
nectin on FFA-stimulated monocytes. Moreover, we have
analyzed the changing of toll-like receptor 4 (TLR4) on
the surface of monocytes to explore the potential
mechanism underlying the effect of adiponectin.
Materials and methods
Patients signed a written consent conform for tissue col-
lection according to a protocol approved by the Ethic
committee of Human Investigation of Union Hospital,
Huazhong University of Science and Technology
(HUST), which conforms to the Helsinki Declaration.
Donation procedures complied with the laws of the P.R.
China, and the specimens obtained were registered with
the relevant governmental authorities of Hubei Province.
Procurement of specimens
Eleven coronary artery samples (left anterior descending
artery, LAD) combined with the surrounding adipose tis-
sue were obtained from human remains voluntarily sup-
plied by the Department of Anatomy, Tongji Medical
College, HUST. Twelve internal mammary arteries, six
radial arteries and 14 greater saphenous veins were
obtained as bridge vessels from patients who were sched-
uled to undergo CABG surgery, before starting cardio-
pulmonary bypass (CPB) surgery. All collected vessels
were fixed and embedded in paraffin for sectioning and
immunochemical staining. Thirty-four patients who had
been planning cardiac surgery first received selective cor-
onary angiography (CAG). They were divided into a
CAD group (n = 23) and a non-CAD control group
according to the results of the CAG. Biopsy samples of
epicardial adipose tissue (average 0.5-1.0 g) from all sub-
jects and of subcutaneous fat from around the greater
saphenous vein of CAD subjects (who planned to use
this vein as a bridge vessel) were taken prior to heparin
administration for CPB surgery. Each single tissue sample
from one subject was divided into two parts, one part was
fixed and embedded in paraffin for sectioning and immu-
nochemical staining, and the other was shock-frozen and
immediately stored in liquid nitrogen for total RNA
extraction. Pectoral subcutaneous adipose tissues were
also obtained from four patients without heart diseases
with body mass indexes (BMI) ranging from 19 to 23 kg/
m
2 who were undergoing non-cardiac surgery, and these
tissue samples were cryopreserved in profound hypother-
mia as described above.
Histological and immunohistochemical examination
The paraffin-embedded sections of vessels were stained
with hematoxylin and eosin (H&E). The eleven coronary
artery samples were then divided into CAD group and
control group according to the results of pathological
examination. For all vessels and adipose tissue samples,
5-μm-thick whole paraffin-embedded cut sections on
polylysine-coated glass slides were incubated overnight at
4°C with phosphate buffered saline (PBS) containing 0.5%
bovine serum albumin (Sigma-Aldrich, St. Louis, MO,
USA) (PBS/BSA) to block nonspecific binding. The speci-
mens were then incubated with rat polyclonal anti-CD68
antibody (Abcam, Cambridge, MA, USA; 1:50 in PBS/
BSA) overnight at 4°C in a moist incubation chamber.
After washing three times in PBS, specimens were incu-
bated with the secondary antibody against the rat poly-
clonal antibody produced in goat (Boster, Wuhan, China;
1:500 in PBS/BSA). The slides were again washed in PBS
three times and incubated with SABC complex diluted
1:500 for 30 min at room temperature. After a new wash
in PBS, the reaction was developed with chromogen solu-
tion consisting of 0.03% hydrogen peroxide. Color inten-
sity was monitored under a light microscope and
compared with positive controls included in each reac-
tion. The specimens were then washed under running
water for 10 min, counterstained with Harris hematoxylin
for 20 seconds, again washed under running water, dehy-
drated in ethanol, cleared in xylene, and mounted in Per-
mount resin. The immunostained sections were analyzed
under Olympic MX-50 optical microscope. Positive
immunostaining for the specific antibody was analyzed
quantitatively in five fields of the lesion area at large mag-
nification (4 × 100) using a graded grid divided into 10 ×
10 subdivisions and comprising an area of 0.0625 mm
2.
Real time quantitative RT-PCR analysis
Total RNA from frozen adipose tissues stored in liquid
nitrogen was extracted using TRIzol reagent (Invitrogen,
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The reverse transcription reactions were conducted with
Transcriptor First Strand cDNA Synthesis Kit (Roche,
Indianapolis, IN, USA). The oligonucleotide primer
sequences were designed by Premier Primer 5.0 software
as Table 1. b-actin was used as an internal control. The
synthesized first-strand cDNA samples were subjected
to real-time PCR with SYBR Green PCR Master Mix
(Toyobo Bio-Technology, Shanghai, China) and PCR
was performed using ABI Prism 7700 Sequence Detec-
tor (Applied Biosystems, Tokyo, Japan). The integrity of
PCR products was confirmed by dissociation curve ana-
lysis using 2.0 software (Applied Biosystems). The
threshold cycle (CT) values were determined and relative
gene expression was calculated using the formula 2
-ΔΔCT
with pectoral subcutaneous adipose tissues obtained
from non-CAD patients during non-cardiac surgery.
Laboratory methods and enzyme-linked immunosorbent
assay
Peripheral vein blood was drawn in the fasting state, and
serum biochemistries were performed with routine labora-
tory techniques for fasting plasma glucose (FPG), triglycer-
ides (TG), total cholesterol (TC), low-density lipoprotein
cholesterol (LDL-C), high-density lipoprotein cholesterol
(HDL-C), apolipoprotein AI (apo AI), apolipoprotein B
(apo B) and lipoprotein (a) (Lp(a)). Blood samples for
plasma adiponectin measurement from coronary sinus
were collected during right heart catheterization. Adipo-
nectin concentrations in peripheral and coronary sinus
vein plasma were determined by enzyme-linked immuno-
sorbent assay (ELISA) according to the protocol provided
by the manufacturer (ALPCO Diagnostics).
Preparation of human monocytes
Twenty milliliters of whole blood donated by healthy
volunteers was randomly obtained from the Wuhan
Blood Centre, which complied with the Blood Donation
Law of the P.R. China. Monocytes were separated from
anticoagulated whole blood using human lymphocyte
separation medium according to the manufacturer’s
instructions (PAN Biotech, Aidenbach, Germany).
Before treatment, the separated cells were suspended in
a culture bottle with high-glucose RPMI1640 medium
(Gibco, Invitrogen, Australia) supplemented with 10%
fetal bovine serum (Gibco) and maintained at 37°C in a
humidified 5% CO2 atmosphere overnight. After dispo-
sal of non-adherent cells, and thoroughly washing the
adherent cells with phosphate-buffered saline (PBS)
twice, cells were recovered using 0.5% trypsin (Gibco).
For evaluating the percentage of monocytes and the via-
bility of collected cells, immunofluorescence and trypan
blue staining were performed. The concentration of cells
was then adjusted to 1 × 10
6/ml to reserve.
Experiment on stearic acid-stimulated monocytes
Isolated monocytes were equilibrated to a steady state at
densities of 4,000 cells per well in 96-well culture plates
for 4 hours, then the pro-inflammatory effects of stearic
acid (SA) and anti-inflammatory effects of adiponection
on monocytes were tested. First, monocytes were cul-
tured in the presence of 100 ng/ml lipopolysaccharide
(LPS) (Sigma-Aldrich, St. Louis, MO, USA) (positive
control), SA (Sigma-Aldrich) at three different concen-
trations (0.1, 0.5 and 1.0 mM) or PBS (negative control)
for 24 hours. Meanwhile, three different final concentra-
tions of globular adiponectin (gAd) (5, 10 and 20 μg/ml)
(Peprotech, Rocky Hill, NJ, USA) or PBS (negative
control) were added as follows. After incubation for
6 hours, monocytes were stimulated by 0.5 mM SA for
24 hours. In the next experiment, cultured supernatants
were collected and TNF-a and IL-6 concentrations were
quantified according to the manufacturer’s instructions
(R&D Systems, Minneapolis, MN, USA). In these two
Table 1 Real-time quantitative RT-PCR Primers
Gene title Accession number Primer Amplicon size (bp)
Adiponectin XM_290602 Forward 5’-GTCCTAAGGGAGACATGG-3’ 302
Reverse 5’-GATCTTCATGAGGTAGTCAGT-3’
IL-6
a NM_000600 Forward 5’-GTGAAAGCAGCAAAGAGGCA-3’ 276
Reverse 5’-TTGGGTCAGGGGTGGTTATT-3’
TNF-a
b NM_000594 Forward 5’-CCGAGTCTGGGCAGGTCTA-3’ 201
Reverse 5’-CGAAGTGGTGGTCTTGTTGC-3’
TLR4
c NM_138554 Forward 5’-GGCTCACAATCTTATCCAATCT-3’ 129
Reverse 5’-TGATGTAGAACCCGCAAGTC-3’
b-actin NM_001101 Forward 5’- CCAACCGCFAFAAFATGACC-3’ 175
Reverse 5’-GATCTTCATGAGGTAGTCAGT-3’
a Interleukin-6.
b Tumor necrosis factor-a.
c Toll like receptor 4.
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was also measured in monocytes using Histostain-Plus
Kit, following manufacturer’si n s t r u c t i o n s( I n v i t r o g e n ,
CA, USA).
Flow cytometry analysis
Monocytes were plated into a 6-well culture plate at
ad e n s i t yo f1×1 0
6/well and equilibrated at 37°C for
2 hours. Three different concentrations of gAd (5, 10
and 20 μg/ml) or PBS (negative control) were added and
stimulated by 0.5 mM SA as described above. The col-
lected cells were then stained with a dual-color antibody
panel composed of CD14 (eBioscience, San Diego, Calif)
and TLR-4 (BD PharMingen, San Diego, CA, USA ) and
analyzed by 6-fluorescent-parameter BD LSRII (BD
Biosciences, Sparks, MD, USA).
Statistical analysis
Data were presented as means ± SEM. When comparing
groups, one-way ANOVA was used to test for significance.
A value of p < 0.05 was considered statistically significant.
Results
Histological characteristics
CD68 is especially expressed by the mononuclear pha-
gocytic system and highly expressed on the surface of
macrophages [14]. As shown in Figure 1A, no changes
in the vascular endothelium, elastic fibers or adventitia
(including from greater saphenous vein) were observed
in samples from either the internal mammary artery or
radial artery. However, atherosclerosis, elastorrhexis, a
large amount of CD68
+ cell infiltration in the adventitia,
and an obvious zone of CD68
+ cell accumulation was
observed at the interface between the adventitia and epi-
cardial adipose tissue in samples from CAD patients. In
the above five types of blood vessels, the highest density
of CD68
+ cells in coronary arteries from CAD patients
is shown in Figure 1C. Meanwhile, the magnitude of
CD68
+ cell infiltration into epicardial adipose tissue
was significantly higher than that observed in samples
either with or without subcutaneous fat around the
greater saphenous vein in patients with CAD (Figure 1B
and 1D).
Figure 1 Histological studies on blood vessels and adipose tissues. (A) I: Normal coronary arteries presented intact endometrium and
luminal patency; II: Atherosclerosis in the coronary artery, with a degree of stenosis of approximately 75%; III-IV: Internal mammary artery and
radial artery from CAD patients, both showing intact endometrium and luminal patency, respectively; V: Greater saphenous vein from CAD
patients presented luminal patency; I-1:Endothelial cells were intact, SCMs and fibers of intercellular layer are orderly arranged, and scarcely any
CD68
+ cells were observed in the adventitia; II-1: Large amounts of CD68
+ cells infiltrated the adventitia in coronary atherosclerosis, which
formed an accumulation zone; III-1~Ⅴ-1:Internal mammary artery, radial artery and greater saphenous vein were present, respectively, and
obvious infiltration of CD68
+ cells was not observed in the adventitia of each group. I-1~Ⅴ-1 immunohistochemical staining corresponding to
the tissue stained by H&E. (B) The quantity of CD68
+ cells infiltrated into epicardial adipose tissue in CAD was significantly increased. The bar
charts were showing the number of CD68
+ cells per ×100 field in each section of blood vessels (C) and adipose tissues (D), respectively. Date
represented the analysis of minimum of 8 random sections per sample. Values are mean ± SEM. *P < 0.05 vs normal coronary artery in C and
epicardial adipose tissue in non-CAD patients and subcutaneous fat around greater saphenous vein in CAD patients in D. Abbreviations: CAD,
coronary artery disease; SMCs, smooth muscle cells.
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By performing real-time quantitative RT-PCR, the
expression levels of adiponetin, IL-6, TNF-a and TLR4
mRNA in different adipose tissues were examined. As
shown in Figure 2, the expression patterns of these
genes in epicardial adipose tissue in non-CAD patients
were similar to those in subcutaneous fat around the
greater saphenous vein in CAD patients. Comparing the
two types of samples more closely, the gene levels in
epicardial adipose tissue in CAD patients were rather
different. Adiponectin mRNA was poorly expressed, but
IL-6, TNF-a and TLR4 were highly expressed. It would
seem that a strongly negative correlation would be
expected between the levels of adiponectin mRNA and
the other three genes.
Decreased circulating adiponectin level is an independent
risk factor for CAD
It has been reported that the plasma level of adiponectin
in coronary circulation is significantly related to adiponec-
tin expression in epicardial adipose tissue [15]. To investi-
gate whether decreased adiponectin expression in
epicardial fat can be used as a sensitive predictor of coron-
ary atherosclerosis in non-obese patients, we examined the
coronary sinus vein plasma levels of adiponectin and rou-
tine biochemical values, including TG, LDL-C, HDL-C,
TC, FPG, apo AI, apo B and Lp(a), in peripheral vein of
e l d e r l ym a l ew i t hb o d ym a s si n d e x( B M I )<2 5 . 0 ,w h o
received coronary angiography, a routine examination for
patients over the age of 60 years undergoing cardiac sur-
gery to exclude CAD. Subjects were divided into two
groups. Within the CAD group, nine subjects were con-
firmed to have significant (>75%) narrowing of at least one
major coronary artery; the non-CAD group included ele-
ven subjects with smooth coronary arteries. As summar-
ized in Table 2, there was no statistically significant
difference between the two groups for TG, LDL-C,
HDL-C, TC, FPG, apo AI, apo B and Lp(a), but the adipo-
nectin concentrations in peripheral and coronary sinus
vein plasma were both significantly lower in the CAD
group suggesting that decreased circulating adiponectin
may play an independent role in the pathogenesis of cor-
onary atherosclerosis.
Adiponectin suppresses inflammatory cytokines secretion
and apoptosis of SA-stimulated monocytes
Using density gradient centrifugation techniques as
described above, we successfully enriched monocytes
from human whole blood. Studies on the expression of
monoclonal antibodies demonstrate that CD14 is a spe-
cific marker for monocytic cells, so immunofluorescence
was performed to identify the percentage of CD14 posi-
tive cells [16]. Results confirmed that the purity of
monocytes in the isolated cells was more than 90% (data
not shown) and that cell viability was over 95% as deter-
mined by staining with trypan blue. TNF-a and IL-6 are
critical cytokines that respond to the progression of
atherosclerosis [17]. To examine the proinflammatory
effect of SA on monocyte secretion of TNF-a and IL-6,
we added SA into the medium to a final concentration
of 0.1, 0.5 and 1.0 mM. PBS and 100 ng/ml LPS were
Figure 2 Quantitative comparison of gene expression among
adipose tissues. After normalization to b-actin, relative adiponectin,
IL-6, TNF-a and TLR4 mRNA transcription level were expressed as
compared to pectoral subcutaneous adipose tissue obtained from
four patients without heart diseases, which was set equal to 1.
Relative adiponectin, IL-6, TNF-a and TLR4 mRNA expression was
measured by real time quantitative RT-PCR in different adipose
tissues. Results are the mean of triplicate measurements repeated
twice. *P < 0.05 vs epicardial fat in non-CAD patients and
subcutaneous fat around greater saphenous vein in CAD patients.
Abbreviations: IL-6, interleukin-6; TNF-a, tumor necrosis factor-a;
TLR-4, toll-like receptor 4; CAD, coronary artery disease.







age (years) 71 ± 9 69 ± 11 n.s.
BMI (Kg/m
2) 23 ± 1.7 22 ± 2.1 n.s.
FPG (mM) 5.2 ± 1.4 5.1 ± 1.8 n.s.
TG (mM) 3.9 ± 1.6 4.0 ± 1.5 n.s.
TC (mM) 1.7 ± 0.6 1.6 ± 0.7 n.s.
HDL-C (mM) 1.1 ± 0.3 1.2 ± 0.5 n.s.
LDL-C (mM) 1.9 ± 0.7 2.0 ± 0.5 n.s.
apo AI (g/l) 0.9 ± 0.2 1.0 ± 0.3 n.s.
apo B (g/l) 0.8 ± 0.3 0.9 ± 0.1 n.s.
Lp(a) (mg/dl) 29 ± 17 32 ± 16 n.s.
peripheral plasma adiponectin (μg/ml) 5.9 ± 1.4 10.3 ± 2.2 <0.01
coronary sinus plasma adiponectin (μg/ml) 4.5 ± 1.9 12.7 ± 3.1 <0.01
Date are expressed as mean ± SD. Abbreviations: BMI, body mass index; FPG,
fasting plasma glucose; TG, triglycerides; TC, total cholesterol; HDL-C, high-
density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; apo
AI, apolipoprotein AI; apo B, apolipoprotein B; lipoprotein (a), Lp(a).
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Compared with negative controls, SA had a stimulatory
effect on monocyte secretion of TNF-a and IL-6, and
an obvious dose-response relationships was observed
between SA and both TNF-a and IL-6 (Figure 3A and
3C). Adioponectin is present in trimer form, and gAd is
its proteolytic cleavage product [18]. To address the
antiinflammatory effects of adiponectin, different con-
centrations of gAd were tested. Compared with PBS,
gAd can inhibit stimulated monocytes secreting TNF-a
and IL-6 (Figure 3B and 3D). Consistent with these
results, SA can active NF-B and induce monocyte
apoptosis, which can be inhibited by gAd (Figure 3E
and 3F).
Adiponectin suppresses TLR4 expression of SA-stimulated
monocytes
As analyzed by real time quantitative RT-PCR, epicardial
adipose tissue exhibited a relatively high level of TLR4
mRNA consistent with inflammatory cytokines IL-6 and
TNF-a. However, the level of adiponectin mRNA is rela-
tively low. To understand the relationship between
expression levels of TLR4 mRNA and the inflammatory
cytokines, we used CD14 and TLR4 antibodies applicable
for flow cytometry (FCM). FCM of monocytes was
observed on samples collected from three different gAd
concentration groups after stimulation with SA. We
observed a significant decrease in the ratio of TLR4 posi-
tive cells as the treatment concentration of gAd increased
from low to high (Figure 4). These results strongly sug-
gest that adiponectin down-regulates the expression of
TLR4 when monocytes are treated with SA.
Discussion
The present study reports the results of investigating
adiponectin and inflammatory cytokines secretion in
epicardial adipose tissue in non-CAD and CAD patients.
A low level of adiponectin was found in the latter,
coupled with a high level of IL-6 and TNF-a. Consistent
with our findings, Baker et al. reported that expression
of other cytokines in epicardial adipose tissue, including
resistin, CD45 and angiotensinogen, were also signifi-
cantly different in CAD patients compared to non-CAD
controls [19]. These results suggest that change in the
excretion profile of cytokines is a key player in the pro-
gression of CAD.
With the use of CD68 as a macrophage marker, we
found that the level of macrophage infiltration in epicar-
dial adipose tissue in CAD patients is higher than in
non-CAD patients. In vitro and in vivo evidence has
been provided to show that FFA, which is released from
the adipocytes contributing to macrophage-induced adi-
pocyte lipolysis, may play a role in the infiltration of
macrophages into adipose tissue [20,21]. Macrophages
participate in an arterial immune-inflammatory reaction
triggered by LDL-C [22]. Data in this study demonstrate
that the expression of IL-6 and TNF-a increases in epi-
cardial adipose tissue in CAD patients resulted in aggre-
gation of abundant macrophages, suggesting that IL-6
and TNF-a take part in this process.
Adiponectin is an important secreted serum protein
[12,23,24]. The human adiponectin gene is located on
chromosome 3q27 [25], and it codes for a 244 amino
acid polypeptide with a signal sequence [23]. It is pre-
sent in human plasma and adipose tissue and is induced
during adipogenesis [12]. Adiponectin has beneficial
roles for the vascular system and it has been proven
that decreased plasma levels of adiponectin are asso-
ciated with vascular events such as diabetic foot [26]
and coronary atherosclerosis [27]. The current study
presents data from epicardial adipose tissue, which is
metabolically active and generates various bioactive
molecules [9]. Results of this study demonstrated a
significant inverse relationship between the level of
adiponectin and IL-6 or TNF-a.
We also focused on the role of reduced expression of
adiponectin in epicardial adipose tissue in the pathogen-
esis of coronary atherosclerosis, although previous study
has proven that abdominal adiposity might play a more
significant role [28]. We found that decreased circulat-
ing adiponectin-induced coronary atherosclerosis might
be independent of plasma levels of glucose and lipids,
which suggests that high glucose and lipids concentra-
tions are not necessary for disorders of epicardial
adipose tissue biology or CAD. Otherwise, our data
strongly suggest that epicardial fat is an important
secretion source of adiponectin and that the peripheral
plasma adiponectin level at least partly influenced by it.
Adiponectin levels in the peripheral circulation were
also better related to intracoronary adiponectin [15,29].
Given a recent report [30], we conclude that a combina-
tion of the concentration of peripheral plasma adiponec-
tin and the thickness of epicardial adipose tissue may be
used as a highly sensitive predictor for coronary athero-
sclerosis in non-obese populations.
In vitro cell experiments showed that adiponectin
could suppresses the cytokines secretion of stimulated
monocytes and that the concentration of endogenous
ligand was essential for activation of the TLR4-mediated
signaling pathway. Plasma SA was elevated more than
2 to 3 times in samples from obese patients compared
to normal samples [31]. An excessive level of SA in
plasma can contribute to expression of TLR4 and activa-
tion of the TLR4-mediated signaling pathway, which
leads to macrophage migration and subsequent trigger-
ing of AS [32]. Our study shows that adiponectin can
down-regulate TLR-4 expression, which decreases
inflammation by reducing SA combined with TLR4.
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showed that obvious dose-effect relationships exist between TNF-a and IL-6 secretion by monocytes and SA; (B and D) Monocytes were treated
with various concentrations of gAd along with 0.5 mM SA. The histograms showed that gAd had an inhibitory effect on monocyte secretion of
TNF-a and IL-6. (E and F) SA could active NF-B, and the process could be inhibited by gAd. PBS and LPS were used as negative and positive
control, respectively. Data are mean ± SEM. *P < 0.05 vs negative control and
†P < 0.05 vs positive control. Triplicate experiments were
performed with essentially identical results. Abbreviations: IL-6, interleukin-6; TNF-a, tumor necrosis factor-a; SA, stearic acid; gAd, globular
adiponectin; PBS, phosphate buffered saline; LPS, lipopolysaccharide.
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Although we revealed that there was no obvious change
in the biological properties of subcutaneous fat, endo-
crine disorders in other visceral fat such as abdominal fat
could not be excluded in non-obese CAD patients, giving
that Cheng KH et al. demonstrated that the tissue level
of adiponectin in abdominal fat was significantly lower
than epicardial fat in CAD patients [28]. Thus, further
studies are needed to characterize the relative contribu-
tion of epicardial fat. In addition, Almeda-Valdes P et al.
showed that total adiponectin, high molecular weight adi-
ponectin (HMWA) and the HMWA/total adiponectin
index had similar utility for identifying insulin resistance
and metabolic disturbances [33], but whether clinical dif-
ferences exist between them for predicting risk of coron-
ary atherosclerosis is still unclear.
Conclusions
In conclusion, this research confirms that immunologic
endocrine disorders in epicardial adipose tissue are
strongly linked to CAD. High production of proinflam-
matory factors in CAD patients is due to changes in the
biological properties of epicardial adipose tissue, which
may be independently associated with increased plasma
glucose and lipid levels. Otherwise, obesity-associated
endocrine disorders in adipocytes can activate mono-
cytes and subsequently trigger atherosclerosis, and adi-
ponectin can inhibit this process through decreasing
TLR4 expression on macrophage/monocytes. Concern is
increasing about the role of epicardial adipose tissue in
the development of CAD. A more thorough understand-
ing of local myocardial inflammation and ischemia
induced by epicardial adipose tissue will provide clues
to the efficient prediction and treatment of CAD.
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